Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

By B. Brenner, M. Cooper, D. Zeeuw. 2002

658 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Cardiology and Cardiovascular Medicine, Economics and Econometrics

View Paper: https://www.semanticscholar.org/paper/0352821c68fa45df63412de858c260d116bc5551

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Giuseppe Remuzzi
2. M. Cooper
3. V. Basevi

Citations in the corpus

• Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. (2004, methodology): “Results from two large clinical trials using Ang II antagonists to treat type 2 diabetic patients with albuminuria, the IDNT Trial [10] and the RENAAL Study [11], reveal the striking benefits of blocking the RAS on preserving renal function.”